ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dendritic Cell Vaccine Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-24A11018
Home | Market Reports | Health| Pharmacy
Global Dendritic Cell Vaccine Market Research Report 2022
BUY CHAPTERS

Global Dendritic Cell Vaccine Market Research Report 2025

Code: QYRE-Auto-24A11018
Report
January 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
3M
Activarti
Argos Therapeutics
Batavia Bioservices
Bellicum Pharmaceuticals
Creagene
DanDrit Biotech
DCPrime
Elios Therapeutics
ImmunoCellular Therapeutics
Immunicum
Kiromic
MediGene AG
Merck
Sanpower Corporation (Dendreon Corporation)

Dendritic Cell Vaccine Market Size

The global market for Dendritic Cell Vaccine was valued at US$ 68.9 million in the year 2024 and is projected to reach a revised size of US$ 85 million by 2031, growing at a CAGR of 3.1% during the forecast period.

Dendritic Cell Vaccine Market

Dendritic Cell Vaccine Market

Dendritic cells (DCs) have several characteristics that make them an ideal vehicle for tumor vaccines, and with the first US FDA-approved DC-based vaccine in use for the treatment of prostate cancer, this technology has become a promising new therapeutic option.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dendritic Cell Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dendritic Cell Vaccine.
The Dendritic Cell Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dendritic Cell Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dendritic Cell Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Dendritic Cell Vaccine Market Report

Report Metric Details
Report Name Dendritic Cell Vaccine Market
Accounted market size in year US$ 68.9 million
Forecasted market size in 2031 US$ 85 million
CAGR 3.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Non-Targeted
  • Target
Segment by Application
  • Covid-19
  • Cancer
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company 3M, Activarti, Argos Therapeutics, Batavia Bioservices, Bellicum Pharmaceuticals, Creagene, DanDrit Biotech, DCPrime, Sanpower Corporation (Dendreon Corporation), Elios Therapeutics, ImmunoCellular Therapeutics, Immunicum, Kiromic, Medigene, Merck & Co.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Dendritic Cell Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Dendritic Cell Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Dendritic Cell Vaccine Market growing?

Ans: The Dendritic Cell Vaccine Market witnessing a CAGR of 3.1% during the forecast period 2025-2031.

What is the Dendritic Cell Vaccine Market size in 2031?

Ans: The Dendritic Cell Vaccine Market size in 2031 will be US$ 85 million.

Who are the main players in the Dendritic Cell Vaccine Market report?

Ans: The main players in the Dendritic Cell Vaccine Market are 3M, Activarti, Argos Therapeutics, Batavia Bioservices, Bellicum Pharmaceuticals, Creagene, DanDrit Biotech, DCPrime, Sanpower Corporation (Dendreon Corporation), Elios Therapeutics, ImmunoCellular Therapeutics, Immunicum, Kiromic, Medigene, Merck & Co.

What are the Application segmentation covered in the Dendritic Cell Vaccine Market report?

Ans: The Applications covered in the Dendritic Cell Vaccine Market report are Covid-19, Cancer, Others

What are the Type segmentation covered in the Dendritic Cell Vaccine Market report?

Ans: The Types covered in the Dendritic Cell Vaccine Market report are Non-Targeted, Target

Recommended Reports

Human Vaccines

Immunotherapy & Cell

Vaccine Adjuvants & Delivery

1 Dendritic Cell Vaccine Market Overview
1.1 Product Definition
1.2 Dendritic Cell Vaccine by Type
1.2.1 Global Dendritic Cell Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Non-Targeted
1.2.3 Target
1.3 Dendritic Cell Vaccine by Application
1.3.1 Global Dendritic Cell Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Covid-19
1.3.3 Cancer
1.3.4 Others
1.4 Global Dendritic Cell Vaccine Market Size Estimates and Forecasts
1.4.1 Global Dendritic Cell Vaccine Revenue 2020-2031
1.4.2 Global Dendritic Cell Vaccine Sales 2020-2031
1.4.3 Global Dendritic Cell Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Dendritic Cell Vaccine Market Competition by Manufacturers
2.1 Global Dendritic Cell Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Dendritic Cell Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Dendritic Cell Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Dendritic Cell Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dendritic Cell Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dendritic Cell Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Dendritic Cell Vaccine, Date of Enter into This Industry
2.8 Global Dendritic Cell Vaccine Market Competitive Situation and Trends
2.8.1 Global Dendritic Cell Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Dendritic Cell Vaccine Players Market Share by Revenue
2.8.3 Global Dendritic Cell Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dendritic Cell Vaccine Market Scenario by Region
3.1 Global Dendritic Cell Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Dendritic Cell Vaccine Sales by Region: 2020-2031
3.2.1 Global Dendritic Cell Vaccine Sales by Region: 2020-2025
3.2.2 Global Dendritic Cell Vaccine Sales by Region: 2026-2031
3.3 Global Dendritic Cell Vaccine Revenue by Region: 2020-2031
3.3.1 Global Dendritic Cell Vaccine Revenue by Region: 2020-2025
3.3.2 Global Dendritic Cell Vaccine Revenue by Region: 2026-2031
3.4 North America Dendritic Cell Vaccine Market Facts & Figures by Country
3.4.1 North America Dendritic Cell Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Dendritic Cell Vaccine Sales by Country (2020-2031)
3.4.3 North America Dendritic Cell Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dendritic Cell Vaccine Market Facts & Figures by Country
3.5.1 Europe Dendritic Cell Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Dendritic Cell Vaccine Sales by Country (2020-2031)
3.5.3 Europe Dendritic Cell Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dendritic Cell Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Dendritic Cell Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Dendritic Cell Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Dendritic Cell Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Dendritic Cell Vaccine Market Facts & Figures by Country
3.7.1 Latin America Dendritic Cell Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Dendritic Cell Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Dendritic Cell Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dendritic Cell Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Dendritic Cell Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Dendritic Cell Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Dendritic Cell Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dendritic Cell Vaccine Sales by Type (2020-2031)
4.1.1 Global Dendritic Cell Vaccine Sales by Type (2020-2025)
4.1.2 Global Dendritic Cell Vaccine Sales by Type (2026-2031)
4.1.3 Global Dendritic Cell Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Dendritic Cell Vaccine Revenue by Type (2020-2031)
4.2.1 Global Dendritic Cell Vaccine Revenue by Type (2020-2025)
4.2.2 Global Dendritic Cell Vaccine Revenue by Type (2026-2031)
4.2.3 Global Dendritic Cell Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Dendritic Cell Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Dendritic Cell Vaccine Sales by Application (2020-2031)
5.1.1 Global Dendritic Cell Vaccine Sales by Application (2020-2025)
5.1.2 Global Dendritic Cell Vaccine Sales by Application (2026-2031)
5.1.3 Global Dendritic Cell Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Dendritic Cell Vaccine Revenue by Application (2020-2031)
5.2.1 Global Dendritic Cell Vaccine Revenue by Application (2020-2025)
5.2.2 Global Dendritic Cell Vaccine Revenue by Application (2026-2031)
5.2.3 Global Dendritic Cell Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Dendritic Cell Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 3M
6.1.1 3M Company Information
6.1.2 3M Description and Business Overview
6.1.3 3M Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 3M Dendritic Cell Vaccine Product Portfolio
6.1.5 3M Recent Developments/Updates
6.2 Activarti
6.2.1 Activarti Company Information
6.2.2 Activarti Description and Business Overview
6.2.3 Activarti Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Activarti Dendritic Cell Vaccine Product Portfolio
6.2.5 Activarti Recent Developments/Updates
6.3 Argos Therapeutics
6.3.1 Argos Therapeutics Company Information
6.3.2 Argos Therapeutics Description and Business Overview
6.3.3 Argos Therapeutics Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Argos Therapeutics Dendritic Cell Vaccine Product Portfolio
6.3.5 Argos Therapeutics Recent Developments/Updates
6.4 Batavia Bioservices
6.4.1 Batavia Bioservices Company Information
6.4.2 Batavia Bioservices Description and Business Overview
6.4.3 Batavia Bioservices Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Batavia Bioservices Dendritic Cell Vaccine Product Portfolio
6.4.5 Batavia Bioservices Recent Developments/Updates
6.5 Bellicum Pharmaceuticals
6.5.1 Bellicum Pharmaceuticals Company Information
6.5.2 Bellicum Pharmaceuticals Description and Business Overview
6.5.3 Bellicum Pharmaceuticals Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bellicum Pharmaceuticals Dendritic Cell Vaccine Product Portfolio
6.5.5 Bellicum Pharmaceuticals Recent Developments/Updates
6.6 Creagene
6.6.1 Creagene Company Information
6.6.2 Creagene Description and Business Overview
6.6.3 Creagene Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Creagene Dendritic Cell Vaccine Product Portfolio
6.6.5 Creagene Recent Developments/Updates
6.7 DanDrit Biotech
6.7.1 DanDrit Biotech Company Information
6.7.2 DanDrit Biotech Description and Business Overview
6.7.3 DanDrit Biotech Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 DanDrit Biotech Dendritic Cell Vaccine Product Portfolio
6.7.5 DanDrit Biotech Recent Developments/Updates
6.8 DCPrime
6.8.1 DCPrime Company Information
6.8.2 DCPrime Description and Business Overview
6.8.3 DCPrime Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 DCPrime Dendritic Cell Vaccine Product Portfolio
6.8.5 DCPrime Recent Developments/Updates
6.9 Sanpower Corporation (Dendreon Corporation)
6.9.1 Sanpower Corporation (Dendreon Corporation) Company Information
6.9.2 Sanpower Corporation (Dendreon Corporation) Description and Business Overview
6.9.3 Sanpower Corporation (Dendreon Corporation) Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sanpower Corporation (Dendreon Corporation) Dendritic Cell Vaccine Product Portfolio
6.9.5 Sanpower Corporation (Dendreon Corporation) Recent Developments/Updates
6.10 Elios Therapeutics
6.10.1 Elios Therapeutics Company Information
6.10.2 Elios Therapeutics Description and Business Overview
6.10.3 Elios Therapeutics Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Elios Therapeutics Dendritic Cell Vaccine Product Portfolio
6.10.5 Elios Therapeutics Recent Developments/Updates
6.11 ImmunoCellular Therapeutics
6.11.1 ImmunoCellular Therapeutics Company Information
6.11.2 ImmunoCellular Therapeutics Description and Business Overview
6.11.3 ImmunoCellular Therapeutics Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 ImmunoCellular Therapeutics Dendritic Cell Vaccine Product Portfolio
6.11.5 ImmunoCellular Therapeutics Recent Developments/Updates
6.12 Immunicum
6.12.1 Immunicum Company Information
6.12.2 Immunicum Description and Business Overview
6.12.3 Immunicum Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Immunicum Dendritic Cell Vaccine Product Portfolio
6.12.5 Immunicum Recent Developments/Updates
6.13 Kiromic
6.13.1 Kiromic Company Information
6.13.2 Kiromic Description and Business Overview
6.13.3 Kiromic Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Kiromic Dendritic Cell Vaccine Product Portfolio
6.13.5 Kiromic Recent Developments/Updates
6.14 Medigene
6.14.1 Medigene Company Information
6.14.2 Medigene Description and Business Overview
6.14.3 Medigene Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Medigene Dendritic Cell Vaccine Product Portfolio
6.14.5 Medigene Recent Developments/Updates
6.15 Merck & Co.
6.15.1 Merck & Co. Company Information
6.15.2 Merck & Co. Description and Business Overview
6.15.3 Merck & Co. Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Merck & Co. Dendritic Cell Vaccine Product Portfolio
6.15.5 Merck & Co. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dendritic Cell Vaccine Industry Chain Analysis
7.2 Dendritic Cell Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dendritic Cell Vaccine Production Mode & Process Analysis
7.4 Dendritic Cell Vaccine Sales and Marketing
7.4.1 Dendritic Cell Vaccine Sales Channels
7.4.2 Dendritic Cell Vaccine Distributors
7.5 Dendritic Cell Vaccine Customer Analysis
8 Dendritic Cell Vaccine Market Dynamics
8.1 Dendritic Cell Vaccine Industry Trends
8.2 Dendritic Cell Vaccine Market Drivers
8.3 Dendritic Cell Vaccine Market Challenges
8.4 Dendritic Cell Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
3M
Activarti
Argos Therapeutics
Batavia Bioservices
Bellicum Pharmaceuticals
Creagene
DanDrit Biotech
DCPrime
Elios Therapeutics
ImmunoCellular Therapeutics
Immunicum
Kiromic
MediGene AG
Merck
Sanpower Corporation (Dendreon Corporation)
List of Tables
 Table 1. Global Dendritic Cell Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Dendritic Cell Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Dendritic Cell Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Dendritic Cell Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Dendritic Cell Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Dendritic Cell Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Dendritic Cell Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Dendritic Cell Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Dendritic Cell Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Dendritic Cell Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Dendritic Cell Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Dendritic Cell Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Dendritic Cell Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dendritic Cell Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Dendritic Cell Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Dendritic Cell Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Dendritic Cell Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Dendritic Cell Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Dendritic Cell Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Dendritic Cell Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Dendritic Cell Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Dendritic Cell Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Dendritic Cell Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Dendritic Cell Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Dendritic Cell Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Dendritic Cell Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Dendritic Cell Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Dendritic Cell Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Dendritic Cell Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Dendritic Cell Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Dendritic Cell Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Dendritic Cell Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Dendritic Cell Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Dendritic Cell Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Dendritic Cell Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Dendritic Cell Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Dendritic Cell Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Dendritic Cell Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Dendritic Cell Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Dendritic Cell Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Dendritic Cell Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Dendritic Cell Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Dendritic Cell Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Dendritic Cell Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Dendritic Cell Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Dendritic Cell Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Dendritic Cell Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Dendritic Cell Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Dendritic Cell Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Dendritic Cell Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Dendritic Cell Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Dendritic Cell Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Dendritic Cell Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Dendritic Cell Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Dendritic Cell Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Dendritic Cell Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Dendritic Cell Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Dendritic Cell Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Dendritic Cell Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Dendritic Cell Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Dendritic Cell Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Dendritic Cell Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Dendritic Cell Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Dendritic Cell Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Dendritic Cell Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Dendritic Cell Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Dendritic Cell Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Dendritic Cell Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. 3M Company Information
 Table 71. 3M Description and Business Overview
 Table 72. 3M Dendritic Cell Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. 3M Dendritic Cell Vaccine Product
 Table 74. 3M Recent Developments/Updates
 Table 75. Activarti Company Information
 Table 76. Activarti Description and Business Overview
 Table 77. Activarti Dendritic Cell Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Activarti Dendritic Cell Vaccine Product
 Table 79. Activarti Recent Developments/Updates
 Table 80. Argos Therapeutics Company Information
 Table 81. Argos Therapeutics Description and Business Overview
 Table 82. Argos Therapeutics Dendritic Cell Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Argos Therapeutics Dendritic Cell Vaccine Product
 Table 84. Argos Therapeutics Recent Developments/Updates
 Table 85. Batavia Bioservices Company Information
 Table 86. Batavia Bioservices Description and Business Overview
 Table 87. Batavia Bioservices Dendritic Cell Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Batavia Bioservices Dendritic Cell Vaccine Product
 Table 89. Batavia Bioservices Recent Developments/Updates
 Table 90. Bellicum Pharmaceuticals Company Information
 Table 91. Bellicum Pharmaceuticals Description and Business Overview
 Table 92. Bellicum Pharmaceuticals Dendritic Cell Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Bellicum Pharmaceuticals Dendritic Cell Vaccine Product
 Table 94. Bellicum Pharmaceuticals Recent Developments/Updates
 Table 95. Creagene Company Information
 Table 96. Creagene Description and Business Overview
 Table 97. Creagene Dendritic Cell Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Creagene Dendritic Cell Vaccine Product
 Table 99. Creagene Recent Developments/Updates
 Table 100. DanDrit Biotech Company Information
 Table 101. DanDrit Biotech Description and Business Overview
 Table 102. DanDrit Biotech Dendritic Cell Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. DanDrit Biotech Dendritic Cell Vaccine Product
 Table 104. DanDrit Biotech Recent Developments/Updates
 Table 105. DCPrime Company Information
 Table 106. DCPrime Description and Business Overview
 Table 107. DCPrime Dendritic Cell Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. DCPrime Dendritic Cell Vaccine Product
 Table 109. DCPrime Recent Developments/Updates
 Table 110. Sanpower Corporation (Dendreon Corporation) Company Information
 Table 111. Sanpower Corporation (Dendreon Corporation) Description and Business Overview
 Table 112. Sanpower Corporation (Dendreon Corporation) Dendritic Cell Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Sanpower Corporation (Dendreon Corporation) Dendritic Cell Vaccine Product
 Table 114. Sanpower Corporation (Dendreon Corporation) Recent Developments/Updates
 Table 115. Elios Therapeutics Company Information
 Table 116. Elios Therapeutics Description and Business Overview
 Table 117. Elios Therapeutics Dendritic Cell Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Elios Therapeutics Dendritic Cell Vaccine Product
 Table 119. Elios Therapeutics Recent Developments/Updates
 Table 120. ImmunoCellular Therapeutics Company Information
 Table 121. ImmunoCellular Therapeutics Description and Business Overview
 Table 122. ImmunoCellular Therapeutics Dendritic Cell Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. ImmunoCellular Therapeutics Dendritic Cell Vaccine Product
 Table 124. ImmunoCellular Therapeutics Recent Developments/Updates
 Table 125. Immunicum Company Information
 Table 126. Immunicum Description and Business Overview
 Table 127. Immunicum Dendritic Cell Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Immunicum Dendritic Cell Vaccine Product
 Table 129. Immunicum Recent Developments/Updates
 Table 130. Kiromic Company Information
 Table 131. Kiromic Description and Business Overview
 Table 132. Kiromic Dendritic Cell Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Kiromic Dendritic Cell Vaccine Product
 Table 134. Kiromic Recent Developments/Updates
 Table 135. Medigene Company Information
 Table 136. Medigene Description and Business Overview
 Table 137. Medigene Dendritic Cell Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Medigene Dendritic Cell Vaccine Product
 Table 139. Medigene Recent Developments/Updates
 Table 140. Merck & Co. Company Information
 Table 141. Merck & Co. Description and Business Overview
 Table 142. Merck & Co. Dendritic Cell Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Merck & Co. Dendritic Cell Vaccine Product
 Table 144. Merck & Co. Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Dendritic Cell Vaccine Distributors List
 Table 148. Dendritic Cell Vaccine Customers List
 Table 149. Dendritic Cell Vaccine Market Trends
 Table 150. Dendritic Cell Vaccine Market Drivers
 Table 151. Dendritic Cell Vaccine Market Challenges
 Table 152. Dendritic Cell Vaccine Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Dendritic Cell Vaccine
 Figure 2. Global Dendritic Cell Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Dendritic Cell Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Non-Targeted Product Picture
 Figure 5. Target Product Picture
 Figure 6. Global Dendritic Cell Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Dendritic Cell Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Covid-19
 Figure 9. Cancer
 Figure 10. Others
 Figure 11. Global Dendritic Cell Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Dendritic Cell Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Dendritic Cell Vaccine Sales (2020-2031) & (K Units)
 Figure 14. Global Dendritic Cell Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 15. Dendritic Cell Vaccine Report Years Considered
 Figure 16. Dendritic Cell Vaccine Sales Share by Manufacturers in 2024
 Figure 17. Global Dendritic Cell Vaccine Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Dendritic Cell Vaccine Players: Market Share by Revenue in Dendritic Cell Vaccine in 2024
 Figure 19. Dendritic Cell Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Dendritic Cell Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Dendritic Cell Vaccine Sales Market Share by Country (2020-2031)
 Figure 22. North America Dendritic Cell Vaccine Revenue Market Share by Country (2020-2031)
 Figure 23. United States Dendritic Cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Dendritic Cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Dendritic Cell Vaccine Sales Market Share by Country (2020-2031)
 Figure 26. Europe Dendritic Cell Vaccine Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Dendritic Cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Dendritic Cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Dendritic Cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Dendritic Cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Dendritic Cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Dendritic Cell Vaccine Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Dendritic Cell Vaccine Revenue Market Share by Region (2020-2031)
 Figure 34. China Dendritic Cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Dendritic Cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Dendritic Cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Dendritic Cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Dendritic Cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Dendritic Cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Dendritic Cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Dendritic Cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Dendritic Cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Dendritic Cell Vaccine Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Dendritic Cell Vaccine Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Dendritic Cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Dendritic Cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Dendritic Cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Dendritic Cell Vaccine Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Dendritic Cell Vaccine Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Dendritic Cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Dendritic Cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Dendritic Cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Dendritic Cell Vaccine by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Dendritic Cell Vaccine by Type (2020-2031)
 Figure 55. Global Dendritic Cell Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Dendritic Cell Vaccine by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Dendritic Cell Vaccine by Application (2020-2031)
 Figure 58. Global Dendritic Cell Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 59. Dendritic Cell Vaccine Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Cervical Cancer Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pneumonia Vaccine Market Insights Forecast to 2030
Global Peptide Based Vaccines for Cancer Market Research Report 2025
Prostate Cancer Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Peptide Cancer Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Immuno Cell Therapy Market Research Report 2024
Pneumococcal Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Human Diploid Cell Rabies Vaccine Market Research Report 2024
Global Therapeutic Cancer Vaccines Market Research Report 2024
Nanomaterial Based Adjuvants Vaccine Market
Global Tumor Immunity Therapy Market Research Report 2024
Global Pneumococcal Vaccination Market Research Report 2025
Dendritic Cell Cancer Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Dendritic Cell Cancer Vaccine Immunotherapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Research Report 2024
Tumour cell Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Natural Killer Cell Therapeutics Market Research Report 2024
Global Meningococcal Infections Vaccine Market Insights Forecast to 2030
Meningococcal Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Veterinary Vaccine Market
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions